Data / Form D filings / Biostax Corp.
Biostax Corp.: Form D filings
Biostax Corp., a biotechnology company in Winter Park, FL, filed 7 Form D notices with the SEC between 2012 and 2026. The latest, on June 8, 2026, reports an offering of $7.5 million with nothing sold yet to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2431 Aloma Ave, Suite 124, Winter Park, FL, 32792
- Phone
- (888) 613-8802
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1559356
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | New notice | $7,453,728 | $0 | $7,453,728 | 20 | Dec 22, 2025 | sec.gov |
| Aug 31, 2022 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Aug 2, 2022 | New notice | $400,000 | $400,000 | 1 | Jul 19, 2022 | sec.gov | |
| Apr 2, 2015 | New notice | Indefinite | $200,000 | 1 | Mar 14, 2015 | sec.gov | |
| Sep 25, 2013 | Amendment | Indefinite | $2,892,750 | 35 | Sep 20, 2012 | sec.gov | |
| Nov 15, 2012 | Amendment | $3,000,000 | $200,000 | $2,800,000 | 2 | Sep 20, 2012 | sec.gov |
| Oct 2, 2012 | New notice | $3,000,000 | $200,000 | $2,800,000 | 2 | Sep 20, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Noreen Griffin | Executive Officer |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Jun 8, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Biostax Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.